Balolong, Rosemarie C.

HRN: 27-11-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/22/2026
06/29/2026
PO
8ml
Q8
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: